Geschreven door studenten die geslaagd zijn Direct beschikbaar na je betaling Online lezen of als PDF Verkeerd document? Gratis ruilen 4,6 TrustPilot
logo-home
Tentamen (uitwerkingen)

S.T.A.B.L.E. PROGRAM 6TH EDITION 2026 | Complete Solutions | Neonatal Stabilization Exam Guide | Pass Guaranteed - A+ Graded

Beoordeling
-
Verkocht
-
Pagina's
33
Cijfer
A+
Geüpload op
10-05-2026
Geschreven in
2025/2026

Pass the S.T.A.B.L.E. Program 6th Edition Learner/Provider Exam on your first attempt with this comprehensive guide featuring complete solutions based on the official curriculum! This A+ Graded resource for the S.T.A.B.L.E. Program (6th Edition) – Post-Resuscitation/Pre-Transport Stabilization Care of Sick Infants contains verified questions with complete solutions covering all seven essential modules required for learner/provider certification. Featuring comprehensive coverage of Module One: Sugar and Safe Care (glucose homeostasis in newborns, risk factors for neonatal hypoglycemia (preterm, large for gestational age (LGA), small for gestational age (SGA), infant of diabetic mother (IDM), perinatal stress, delayed feeds), screening protocols (point-of-care glucose testing, lab confirmation, appropriate action levels 45 mg/dL followed by confirmatory lab, treatment thresholds based on symptoms, intravenous dextrose administration (10% dextrose solution (D10W) at 80‑100 mL/kg/day or 6‑8 mg/kg/min maintenance glucose infusion rate (GIR), oral feeding with formula or expressed breast milk (EBM) for asymptomatic hypoglycemia (no neuroglycopenic symptoms: jitteriness, lethargy, temperature instability, poor feeding, high‑pitched cry, apnea, seizure, coma)), maternal diabetes management, safe care practices to prevent iatrogenic harm), Module Two: Temperature (neonatal thermoregulation principles (neutral thermal environment (NTE), thermoregulation mechanisms (evaporation (wet infant at birth, dry immediately, radiant warmer, pre‑heated towels), convection (draft avoidance, incubator shielding, radiant warmer with skin temperature servo‑control), conduction (warmed hands, stethoscope, equipment, pre‑heated mattress, skin‑to‑skin contact with mother (kangaroo care) for stable neonates, also effective for hypothermia prevention), radiation (heat loss to solid cooler surfaces, incubator placement away from windows and exterior walls, double‑walling (incubators with double shell reduce radiant loss)), clinical signs of hypothermia (cold skin, decreased activity, respiratory distress, hypoglycemia, metabolic acidosis, poor weight gain), hyperthermia prevention (overheating from radiant warmers, incubators, double‑wrapping, phototherapy heat), normothermia maintenance bundle (axillary thermometry (avoid rectal due to risk of perforation, but if indicated, insert no more than 2‑3 cm, use without force, thin lubricant), temperature monitoring frequency (q15‑30min during stabilization, q1h after transfer to ward), transfer between environments (pre‑heated transport incubator with battery‑powered servo‑control, portable warmer with pre‑charged batteries, disposable chemical warmers as backup but not for direct skin contact due to burn risk), recommended admission temperature target 36.5‑37.5°C (axillary), hypothermia classification (mild 36.0‑36.4°C, moderate 32.0‑35.9°C, severe 32.0°C defined as cold stress)), Module Three: Airway (airway management principles (head positioning – sniffing position (align external auditory meatus with sternal notch, avoid hyperextension or flexion), jaw thrust (if apnea or obstruction), chin lift (for ineffective gas exchange)), airway clearance techniques (suction bulb (oral/nasal secretions, first pass, not deep pharynx to avoid vagal response and bradycardia), catheter suction (10‑12 Fr, 80‑100 mmHg, rotate outward, total suction time 10 seconds, cardiorespiratory monitor attached, pre‑oxygenate with bag‑valve‑mask (BVM) if unstable), meconium aspiration syndrome (MAS) initial steps (non‑vigorous infant delivered through meconium‑stained amniotic fluid (MSAF) – NRP 2015 and 2020 recommended direct laryngoscopy with intubation and tracheal suctioning before stimulation, but 2021 AHA NRP update changed: only if infant has poor muscle tone, poor respiratory effort, heart rate 100, still need to intubate and suction, cannot assume NRP advanced always indicated, refer to current NRP algorithm per institution, vigorous infant may not need intubation, but still must be observed for signs of MAS (tachypnea, grunting, retractions, cyanosis, oxygen requirement, need CPAP or mechanical ventilation)), respiratory distress syndrome (RDS) recognition (tachypnea 60, grunting, retractions (subcostal, intercostal, sternal), nasal flaring, cyanosis, oxygen saturation targeting (in first minutes of life 70‑80%, rise gradually to 90‑95% by 10 minutes, target SpO2 per NRP algorithm, avoid hyperoxia (increased FiO2 60% for prolonged period can damage immature retina (retinopathy of prematurity (ROP) risk inversely proportional to gestational age: 23 weeks highest risk, 30 weeks moderate, 34+ weeks minimal, but still screen per AAP guidelines)), CPAP delivery (continuous positive airway pressure via nasal prongs, mask (but nasal interface preferred because less gastric insufflation and better tolerance) or endotracheal tube (ETT) for intubated patients), mechanical ventilation settings (PIP (peak inspiratory pressure) 15‑25 cmH2O, PEEP (positive end‑expiratory pressure) 5‑6 cmH2O, rate (RR) 20‑60 breaths/minute, tidal volume (VT) 4‑6 mL/kg, inspiratory time (Ti) 0.3‑0.5 seconds, I:E ratio 1:1 to 1:2, FiO2 adjusted to SpO2 target), surfactant administration (for infants with RDS requiring FiO2 30% and needing intubation, prophylactic (within 15‑30 minutes of birth, 30‑60 minutes intratracheal) vs rescue (after signs of RDS, within 2 hours), dosing (beractant (Survanta) 100 mg/kg phospholipids (4 mL/kg), diluted), poractant alfa (Curosurf) initial dose 200 mg/kg (2.5 mL/kg), may repeat 100 mg/kg (1.25 mL/kg) up to two additional doses), post‑administration management (ventilator settings may need to be decreased within 10‑15 minutes, avoid dislodging ETT several centimeters due to position change, in some ETT may be converted to CPAP after extubation depending on clinical stability), respiratory monitoring (ETT placement depth confirmation by capnography, chest X‑ray at the carina, orogastric tube for decompression to reduce gastric distension and improve ventilation), Module Four: Blood Pressure (neonatal hypotension identification (systemic blood pressure below 5th percentile for gestational age and weight, commonly defined as mean arterial pressure (MAP) less than gestational age in weeks (physiological threshold) or MAP 30 mmHg for term, 25 mmHg for preterm, with signs of hypoperfusion (low urine output 1 mL/kg/hour, capillary refill 3 seconds, metabolic acidosis (base excess (BE) less than -10 mmol/L, lactate 4 mmol/L), altered mental status, mottled skin, weak peripheral pulses, tachycardia, bradycardia in late shock)), causes of neonatal shock (hypovolemic (placental abruption, fetomaternal hemorrhage, twin‑twin transfusion, umbilical cord avulsion, birth trauma, surgical blood loss, internal hemorrhage (intraventricular hemorrhage (IVH), adrenal, hepatic, splenic rupture)), distributive/septic (early‑onset neonatal sepsis (GBS, E. coli, Listeria, other gram‑negative pathogens), inflammatory response, capillary leak), cardiogenic (congenital heart disease (CHD) (hypoplastic left heart syndrome (HLHS), coarctation of aorta, critical aortic stenosis, interrupted aortic arch), myocardial dysfunction (perinatal asphyxia, hypoxic‑ischemic encephalopathy (HIE), metabolic acidosis, electrolyte disorders, sepsis, arrhythmias (supraventricular tachycardia (SVT) with rate 220 causing poor cardiac output))), obstructive (pneumothorax (tension physiology), congenital diaphragmatic hernia (CDH) with mediastinal shift, pericardial effusion causing tamponade), treatment of hypotension (volume expansion (10 mL/kg normal saline (NS) or lactated Ringer's (LR), may repeat up to 20‑40 mL/kg total, avoid overexpansion because can worsen cardiac function if cardiogenic etiology), vasopressors (dopamine (2‑20 mcg/kg/min, starting at 5‑10 mcg/kg/min, titrate to MAP, monitor for arrhythmias (tachyarrhythmias, PVCs, tachycardia), dobutamine (2‑20 mcg/kg/min, for low cardiac output with adequate or high MAP but signs of hypoperfusion), epinephrine (0.05‑2 mcg/kg/min for refractory shock after fluids and dopamine), norepinephrine (0.05‑2 mcg/kg/min for vasodilatory shock (sepsis, spinal cord injury)), hydrocortisone (1‑2 mg/kg IV q6‑12h for suspected adrenal insufficiency (refractory shock with inotrope resistance, often in extremely low birth weight (ELBW) infants, perinatal asphyxia, sepsis))), neonatal blood pressure monitoring (non‑invasive oscillometric measurement (cuff size appropriate: cuff width 50‑75% of upper arm length, bladder length covers 80‑100% of arm circumference, also thigh cuff if arm not accessible), invasive arterial line (if severe instability, need for frequent monitoring, arterial blood gas sampling, ongoing vasoactive infusion)), Module Five: Lab Work (essential neonatal lab values (normal ranges for hematocrit (Hct 45‑65%, higher in term infants than preterm, lower threshold for transfusion depends on infant and symptoms), hemoglobin (14‑22 g/dL for term), platelet count (150‑450 x 10^9/L, normal by day 3, thrombocytopenia defined 150, severe 50), white blood cell (WBC) (9‑30 x 10^9/L at birth, then 5‑20 by week 1, but elevated may indicate infection, neutropenia may be early sign of sepsis in ELBW), glucose (goal 45‑100 mg/dL (2.5‑5.5 mmol/L), hypoglycemia alert at 45, treat 40 mg/dL if symptomatic, or 25 mg/dL in first 4 hours in asymptomatic, confirm by lab before treatment if time permits but treat empirically in symptomatic), calcium (total Ca 7‑12 mg/dL (1.8‑3.0 mmol/L), ionized Ca 1.0‑1.4 mmol/L (4‑5.6 mg/dL)), magnesium (1.5‑2.3 mg/dL (0.6‑0.95 mmol/L)), sodium (135‑145 mmol/L), potassium (3.5‑5.5 mmol/L), chloride (98‑110 mmol/L), bicarbonate (19‑24 mmol/L), BUN (3‑12 mg/dL), creatinine (0.3‑1.0 mg/dL (higher in first days reflects maternal renal function, then declines)), bilirubin (total 0‑12 mg/dL, risk for severe hyperbilirubinemia if rising rapidly, rule‑out hemolytic disease of newborn (HDN) if elevated direct Coombs test positive, rule‑out pathologic jaundice (first 24 hours of life), exchange transfusion thresholds based on hour‑specific Bhutani nomogram, risk factors for neurotoxicity (hypothermia, acidosis, sepsis, hypoalbuminemia)), blood gas interpretation (pH 7.25‑7.35 for normal newborn (arterial or venous), but slightly lower in first hours, 7.20‑7.40 acceptable, PaO2 50‑80 mmHg (target 50‑70 if on oxygen), PaCO2 35‑45 mmHg (target 45‑55 on mechanical ventilation to avoid hypocarbia which may worsen white matter injury), base excess (BE) -5 to +2 mmol/L indicates normal metabolic status, base deficit 5 mmol/L suggests metabolic acidosis, evaluate for hypoperfusion, renal function, congenital metabolic disorders, inborn errors of metabolism (IEM) screening per state newborn screening panel (PKU, MCAD, VLCAD, G6PD, biotinidase, galactosemia, congenital hypothyroidism, cystic fibrosis, hemoglobinopathies, etc.), point‑of‑care devices (blood gas machine, i‑STAT, glucose meter, lactate meter), laboratory specimen collection (heel stick for capillary sample, venipuncture for the majority of labs (CBC, CRP, blood culture, electrolytes, BUN/creatinine, magnesium, calcium, phosphorus, bilirubin, blood gas for pH/PCO2/PO2/lactate/hematocrit/glucose/electrolytes via i‑STAT, and therapeutic monitoring of vancomycin, gentamicin, phenobarbital (NICU therapeutic drug monitoring))), Module Six: Emotional Support (family‑centered care principles (reduce parent anxiety, promote bonding, improve coping mechanisms, update on infant status with clear language and empathy, language translation services for non‑English speaking families, culturally sensitive communication regarding illness, potential disability, death and dying, religious rituals, spiritual support, education of family on infant's condition (diagnosis, treatment, prognosis, ongoing care plan), involvement of social work, child life, hospital chaplain, palliative care team if infant is critically ill with high risk of mortality or severe neurodevelopmental impairment, support for shared decision‑making regarding life‑sustaining treatment (intubation, resuscitation, redirection of care to comfort measures only when further aggressive care is futile, consult neonatology and palliative care early, document family wishes, advance care planning, facilitate sibling visits (prepare siblings with age‑appropriate language, use of medical play, dolls, books, child life specialists), facilitate grandparent visitation, offer postpartum mental health screening for both parents (Edinburgh Postnatal Depression Scale (EPDS) screening at enrollment and discharge, referral to behavioral health for positive screen (score 10 or 12 depending on cutoff, plus positive answer to item 10 (suicidal ideation) requires immediate evaluation)), refer to perinatal mental health specialist if indicated, encourage skin‑to‑skin contact (kangaroo care) when medically stable, incorporate father/partner in routine care (handwashing, temperature taking, feeding assistance, reading to infant, holding infant in blanket, providing expressed breast milk, medication delivery via syringe or feeding tube, participating in medical rounds, calling nurse call light without hesitation), provide written information (handouts, diagrams, web resources, infant journal for parents to document daily events and progress, help family interpret monitoring equipment (apnea monitor, pulse oximeter, end‑tidal CO2, ventilator settings) without overwhelming detail), establish communication plan (daily updates by bedside nurse, scheduled parent‑provider rounds, family participation in shift change huddle if appropriate, access to social worker for resource linkage (housing instability, food insecurity, transportation to hospital, unemployment, financial strain, legal issues affecting infant's custody or parental rights), connect family with community resources (local Early Intervention Program (Part C of IDEA), support groups (Graham's Foundation, PEP (Premature Empowerment Program) for NICU parents, Hand to Hold, March of Dimes NICU Family Support, Project Sweet Peas, PreemieWorld, Miracle Babies, TinySuperheroes, Rachel's Gift, Molly Bear, Now I Lay Me Down to Sleep (infant bereavement photography), Teeny Tears (handmade diapers for micro preemies), Precious Preemie (clothing for micro preemies, weight‑specific patterns), Facebook NICU support groups (local chapters, general NICU parent forums)), offer interpreter services for limited English proficiency (LEP) families and for American Sign Language (ASL) for deaf or hard of hearing parents), Module Seven: Quality Improvement (professional responsibility for improving and evaluating neonate safety and care quality, QI methodologies in neonatal context (Plan‑Do‑Study‑Act (PDSA) cycles, Lean methodology, Six Sigma, root cause analysis (RCA) for sentinel events, failure mode and effects analysis (FMEA) for neonatal near‑miss events, safety culture assessment, just culture, second victim support, disclosure and apology for medical errors, peer review, quality metrics (neonatal hypothermia rate on admission, unplanned extubation rate, central line‑associated bloodstream infection (CLABSI) rate, catheter‑associated urinary tract infection (CAUTI) rate, ventilator‑associated pneumonia (VAP) rate for neonatal intubated patients, antibiotic stewardship (duration of therapy for rule‑out sepsis (generally 48‑72 hours if cultures negative), antibiotic use metrics, intubation rate in delivery room, surfactant administration within 2 hours of birth, CPAP use for RDS, therapeutic hypothermia for perinatal asphyxia, neonatal abstinence syndrome (NAS) protocol adherence, parental satisfaction scores, family presence during rounds, documentation of family update within 24 hours of admission, adherence to sepsis screening (early warning scores (NEWS, PEWS), neonatal resuscitation checklist completed after every resuscitation event, data submission to Vermont Oxford Network (VON) for benchmarking, use of standardized handoff tool (I‑PASS, SHARED) between shifts, structured team debriefing after high‑stakes events (code blue, death, severe morbidity), peer support for staff after adverse event, staff wellness initiatives (resiliency training, Schwartz Rounds, employee assistance program (EAP), no‑blame reporting for near‑miss events, annual safety competency training, just‑in‑time simulation drills (extremely low birth weight (ELBW) delivery, meconium aspiration, congenital diaphragmatic hernia (CDH) stabilization, neonatal seizure, air leak syndrome, and cardiac emergency)), it provides the exact practice needed to master the official S.T.A.B.L.E. Program 6th Edition Learner/Provider Exam. With detailed rationales, post‑resuscitation stabilization algorithms, clinical case scenarios, glucose management protocols, thermoregulation bundles, airway clearance techniques, blood pressure management and vasoactive infusions, lab value interpretation, family‑centered communication strategies, quality improvement frameworks, and our Pass Guarantee, this is the definitive tool for neonatal nurses, respiratory therapists, physicians, and maternal‑infant caregivers seeking S.T.A.B.L.E. certification. Download now and earn your S.T.A.B.L.E. Provider credential with confidence!

Meer zien Lees minder
Instelling
S.T.A.B.L.E. PROGRAM 6TH EDITION
Vak
S.T.A.B.L.E. PROGRAM 6TH EDITION

Voorbeeld van de inhoud

​S.T.A.B.L.E. PROGRAM 6TH​
​EDITION 2026 | Complete​
​Solutions | Neonatal Stabilization​
​Exam Guide | Pass Guaranteed -​
​A+ Graded​
​### **Sugar Module (Q1–10)**​

*​ *Q1:** A 2-hour old term infant, born to a diabetic mother, has a point-of-care glucose of 38​
​mg/dL (2.1 mmol/L). The infant is asymptomatic. What is the most appropriate initial​
​intervention?​

​ . Begin a continuous infusion of D10W at 60 mL/kg/day​
A
​B. Administer 2 mL/kg of D10W IV push over 1–2 minutes​
​C. Feed the infant formula or breast milk​
​D. Give 1 mL/kg of D25W IV push​

​**[CORRECT]** C​

*​ Rationale: Per S.T.A.B.L.E. 6th Edition, for asymptomatic hypoglycemia (glucose 25–45​
​mg/dL), oral feeding (breast milk or formula) is first-line intervention. Option B is reserved for​
​symptomatic or severe hypoglycemia (<25 mg/dL). D25W (Option D) is too hyperosmolar for​
​neonates and can cause IV infiltration injury and rebound hypoglycemia. Test tip: Always assess​
​for symptoms first—"asymptomatic low glucose gets feeding, symptomatic gets IV."*​

​---​

*​ *Q2:** Which of the following infants is at HIGHEST risk for developing neonatal hypoglycemia​
​in the first 6 hours of life?​

​ . Term infant, appropriate for gestational age (AGA), born to a mother with well-controlled​
A
​gestational diabetes​
​B. 34-week preterm infant, small for gestational age (SGA), with birth weight 1,600 g​

,​ . Term infant, large for gestational age (LGA), born to a mother with type 1 diabetes mellitus​
C
​D. 38-week infant with polycythemia (hematocrit 68%)​

​**[CORRECT]** B​

*​ Rationale: Per S.T.A.B.L.E. 6th Edition, SGA and preterm infants have the highest risk due to​
​depleted glycogen stores, impaired gluconeogenesis, and increased metabolic demands. While​
​IDM-LGA infants (Option C) are high-risk, the combination of prematurity + SGA (Option B)​
​represents the most vulnerable population with minimal substrate reserves. Option A is lower​
​risk due to "well-controlled" diabetes. Option D (polycythemia) can cause hypoglycemia via​
​glucose consumption but is less common than prematurity/SGA.*​

​---​

*​ *Q3:** A 3-hour old, 28-week gestation infant weighing 1,100 g has a glucose of 22 mg/dL (1.2​
​mmol/L) and is jittery with a weak cry. What is the correct management sequence?​

​ . Feed 5 mL of breast milk via gavage tube, then recheck in 30 minutes​
A
​B. Administer 2 mL/kg of D10W IV push over 1–2 minutes, then start D10W continuous infusion​
​at 80 mL/kg/day​
​C. Give 2 mL/kg of D25W IV push, then begin D5W at 60 mL/kg/day​
​D. Apply dextrose gel 0.5 mL/kg to buccal mucosa and observe for 1 hour​

​**[CORRECT]** B​

*​ Rationale: S.T.A.B.L.E. 6th Edition specifies that symptomatic hypoglycemia or glucose <25​
​mg/dL requires IV dextrose: 2 mL/kg D10W IV push (200 mg/kg) over 1–2 minutes, followed by​
​continuous D10W infusion. Option A is inappropriate for a preterm infant who is NPO and​
​symptomatic. Option C uses dangerous D25W (causes phlebitis, hyperosmolality) and​
​inadequate D5W concentration. Option D (dextrose gel) is for asymptomatic, term/near-term​
​infants per AAP guidelines—not for symptomatic preterm infants.*​

​---​

*​ *Q4:** After treating hypoglycemia with IV dextrose, how frequently should point-of-care​
​glucose be monitored until stable?​

​ . Every 5 minutes for the first hour​
A
​B. Every 30–60 minutes until three consecutive readings are within target range​
​C. Every 2 hours for 24 hours​
​D. Only when the infant becomes symptomatic again​

​**[CORRECT]** B​

,*​ Rationale: S.T.A.B.L.E. 6th Edition recommends rechecking glucose every 30–60 minutes after​
​intervention until three consecutive values are within the target range (≥45 mg/dL or ≥2.5​
​mmol/L). Option A is excessive and not evidence-based. Option C is too infrequent during the​
​critical stabilization period. Option D is dangerous—reactive monitoring misses rebound​
​hypoglycemia, which is common after IV dextrose boluses due to insulin surge.*​

​---​

*​ *Q5:** What is the definition of neonatal hypoglycemia per the S.T.A.B.L.E. Program 6th Edition​
​and current AAP guidelines?​

​ . Glucose <60 mg/dL (<3.3 mmol/L) at any time in the first 72 hours​
A
​B. Glucose <45 mg/dL (<2.5 mmol/L) after the first 24 hours of life​
​C. Glucose <40 mg/dL (<2.2 mmol/L) in the first 4 hours, <45 mg/dL thereafter​
​D. Glucose <45 mg/dL (<2.5 mmol/L) at any point in the neonatal period​

​**[CORRECT]** D​

*​ Rationale: The S.T.A.B.L.E. 6th Edition aligns with AAP guidelines defining neonatal​
​hypoglycemia as glucose <45 mg/dL (<2.5 mmol/L) at any point, with operational thresholds of​
​<40 mg/dL in the first 4 hours and <45 mg/dL thereafter. Option A is too high and would​
​overtreat normal transitional hypoglycemia. Option B misses the first 24-hour window. Option C​
​is close but the unified operational threshold is <45 mg/dL for clinical decision-making in​
​S.T.A.B.L.E.*​

​---​

*​ *Q6:** Dextrose gel 40% (200 mg/g) is applied to the buccal mucosa of an asymptomatic,​
​38-week infant with glucose 35 mg/dL. What is the correct dose and next step?​

​ . 0.5 mL/kg, then feed immediately and recheck glucose in 30 minutes​
A
​B. 1.0 mL/kg, then place NPO and observe for 2 hours​
​C. 0.3 mL/kg, then begin IV D10W infusion prophylactically​
​D. 1.5 mL/kg, then send to NICU for continuous monitoring​

​**[CORRECT]** A​

*​ Rationale: Per S.T.A.B.L.E. 6th Edition and AAP guidelines, dextrose gel dose is 0.5 mL/kg​
​(200 mg/kg) applied to buccal mucosa, followed immediately by feeding (breast or formula), with​
​recheck in 30 minutes. Option B is incorrect because the infant should be fed, not made NPO.​
​Option C is overly aggressive for an asymptomatic infant who can be managed with oral​
​interventions. Option D is excessive—dextrose gel is designed to prevent NICU admission for​
​asymptomatic hypoglycemia.*​

, ​---​

*​ *Q7:** An infant with hypoglycemia receives a D10W bolus. Thirty minutes later, the glucose is​
​85 mg/dL. What complication is the nurse most concerned about?​

​ . Hyperglycemia-induced osmotic diuresis​
A
​B. Rebound hypoglycemia from pancreatic insulin surge​
​C. Dextrose-induced necrotizing enterocolitis (NEC)​
​D. Cerebral edema from rapid glucose correction​

​**[CORRECT]** B​

*​ Rationale: S.T.A.B.L.E. 6th Edition emphasizes that IV dextrose boluses can trigger a reactive​
​insulin surge, causing rebound hypoglycemia 30–60 minutes post-bolus—this is why frequent​
​monitoring is critical. Option A (osmotic diuresis) occurs with sustained hyperglycemia >180​
​mg/dL, not a transient 85 mg/dL. Option C is incorrect because IV dextrose does not cause​
​NEC. Option D (cerebral edema) is associated with rapid correction of hypernatremia, not​
​hypoglycemia.*​

​---​

*​ *Q8:** Which maternal condition places the infant at risk for BOTH hypoglycemia AND​
​hypocalcemia?​

​ . Maternal Graves' disease​
A
​B. Maternal diabetes mellitus (any type)​
​C. Maternal phenylketonuria (PKU)​
​D. Maternal chorioamnionitis​

​**[CORRECT]** B​

*​ Rationale: Maternal diabetes mellitus causes fetal hyperinsulinism (hypoglycemia risk) and is​
​associated with delayed parathyroid hormone response leading to hypocalcemia, especially in​
​IDM infants. Option A (Graves' disease) causes neonatal hyperthyroidism/hypothyroidism, not​
​primarily these metabolic issues. Option C (PKU) causes intellectual disability and microcephaly.​
​Option D (chorioamnionitis) causes sepsis risk but not specifically this dual metabolic profile.*​

​---​

*​ *Q9:** A 4-hour old infant has glucose 28 mg/dL. The nurse starts a D10W infusion at 60​
​mL/kg/day. One hour later, glucose is 32 mg/dL. What is the most appropriate next action?​

​ . Increase the infusion rate to 80 mL/kg/day and recheck in 1 hour​
A
​B. Give another 2 mL/kg D10W bolus and increase the infusion concentration to D12.5W​

Geschreven voor

Instelling
S.T.A.B.L.E. PROGRAM 6TH EDITION
Vak
S.T.A.B.L.E. PROGRAM 6TH EDITION

Documentinformatie

Geüpload op
10 mei 2026
Aantal pagina's
33
Geschreven in
2025/2026
Type
Tentamen (uitwerkingen)
Bevat
Vragen en antwoorden

Onderwerpen

$14.99
Krijg toegang tot het volledige document:

Verkeerd document? Gratis ruilen Binnen 14 dagen na aankoop en voor het downloaden kun je een ander document kiezen. Je kunt het bedrag gewoon opnieuw besteden.
Geschreven door studenten die geslaagd zijn
Direct beschikbaar na je betaling
Online lezen of als PDF

Maak kennis met de verkoper
Seller avatar
oketchnyasakwa

Maak kennis met de verkoper

Seller avatar
oketchnyasakwa Chamberlain College Of Nursing
Volgen Je moet ingelogd zijn om studenten of vakken te kunnen volgen
Verkocht
1
Lid sinds
2 maanden
Aantal volgers
0
Documenten
250
Laatst verkocht
3 dagen geleden

0.0

0 beoordelingen

5
0
4
0
3
0
2
0
1
0

Recent door jou bekeken

Waarom studenten kiezen voor Stuvia

Gemaakt door medestudenten, geverifieerd door reviews

Kwaliteit die je kunt vertrouwen: geschreven door studenten die slaagden en beoordeeld door anderen die dit document gebruikten.

Niet tevreden? Kies een ander document

Geen zorgen! Je kunt voor hetzelfde geld direct een ander document kiezen dat beter past bij wat je zoekt.

Betaal zoals je wilt, start meteen met leren

Geen abonnement, geen verplichtingen. Betaal zoals je gewend bent via iDeal of creditcard en download je PDF-document meteen.

Student with book image

“Gekocht, gedownload en geslaagd. Zo makkelijk kan het dus zijn.”

Alisha Student

Bezig met je bronvermelding?

Maak nauwkeurige citaten in APA, MLA en Harvard met onze gratis bronnengenerator.

Bezig met je bronvermelding?

Veelgestelde vragen